Free shipping on all orders over $ 500

Tetrahydropalmatine

Cat. No. M3927
Tetrahydropalmatine Structure
Synonym:

cas#2934-97-6; Rotundine

Size Price Availability Quantity
10mg USD 80  USD80 In stock
50mg USD 120  USD120 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tetrahydropalmatine has been shown to have analgesic effects and may benefit research into heart disease and liver damage. It is a voltage-activated l-type calcium and potassium channel blocker. It has also shown potential in the treatment of addiction to cocaine and opioid compounds, and preliminary human studies have shown promising results. THP treatment significantly increased the activity of key MyoD activating myotropin kinases p38MAPK and Akt. THP treatment restored myoduct formation in C2C12-deficient cells by activating p38MAPK. THP enhanced myOd-mediated transformation and differentiation of 10T1/2 fibroblasts into myoblasts. Tetrahydropalmatine may have a potential research candidate to prevent fibrosis and improve muscle regeneration and repair.

Chemical Information
Molecular Weight 355.43
Formula C21H25NO4
CAS Number 10097-84-4
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Lee SJ, et al. Biochem Biophys Res Commun. Tetrahydropalmatine promotes myoblast differentiation through activation of p38MAPK and MyoD.

Related Dopamine Receptor Products
Cyclo(glycyl-L-leucyl)

Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminergic supersensitivity.

Onzigolide

Onzigolide (BIM-23A760), a chimeric dopamine-somatostatin compound, shows potent agonist activity at both DA type 2 (D2R) and SST type 2 (SSTR2) receptors.

CVL-871

CVL-871 is a partial agonist at dopamine D1/5 receptors and may be used in dementia-related studies.

Paliperidone palmitate

Paliperidone palmitate is the ester precursor compound of Paliperidone, a potent dopamine antagonist and 5-HT2A antagonist. Paliperidone is a potent dopamine antagonist and 5-HT2A antagonist.

Melevodopa

Melevodopaa is an oral precursor compound to Levodopa that enters the body and can pass through the gut and blood-brain barrier into the brain. In the brain, Melevodopa is converted to dopamine, which increases dopamine levels in the brain and can be used in studies related to Parkinson's disease.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tetrahydropalmatine, cas#2934-97-6; Rotundine supplier, Dopamine Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.